Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: May 26, 2025
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review.
Journal: Journal for immunotherapy of cancer
Published: December 12, 2024
Rapidly Evolving Pre- and Post-surgical Systemic Treatment of Melanoma.
Journal: American journal of clinical dermatology
Published: February 07, 2024
Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Journal: Journal for immunotherapy of cancer
Published: September 07, 2023
Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Journal: bioRxiv : the preprint server for biology
Published: September 04, 2023
Tumor cell p38 inhibition to overcome immunotherapy resistance.
Journal: Research square
Published: August 30, 2023
Facts and Hopes in Using Omics to Advance Combined Immunotherapy Strategies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 22, 2023
PD-1 Monotherapy Reigns Supreme in Adjuvant Melanoma…But for How Long?
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 09, 2023
Targeting Cbl-b in cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: January 13, 2023
Progression/Recurrence-Free Survival 2 in Adjuvant Melanoma.
Journal: NEJM evidence
Published: November 01, 2022
Last Updated: 09/26/2026